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Abstract
Background: More than one million new cases of sexually transmitted diseases (STDs) occur each day. The immune
responses and inflammation induced by STDs and other frequent non-STD microbial colonizations (i.e. Candida and
bacterial vaginosis) can have serious pathologic consequences in women including adverse pregnancy outcomes, infertility
and increased susceptibility to infection by other pathogens. Understanding the types of immune mediators that are
elicited in the lower genital tract by these infections/colonizations can give important insights into the innate and adaptive
immune pathways that are activated and lead to strategies for preventing pathologic effects.
Methodology/Principal Findings: 32 immune mediators were measured by multiplexed immunoassays to assess the
immune environment of the lower genital tract mucosa in 84 women attending an urban STD clinic. IL-3, IL-1ß, VEGF,
angiogenin, IL-8, ß2Defensin and ß3Defensin were detected in all subjects, Interferon-a was detected in none, while the
remaining mediators were detected in 40% to 93% of subjects. Angiogenin, VEGF, FGF, IL-9, IL-7, lymphotoxin-a and IL-3
had not been previously reported in genital mucosal fluid from women. Strong correlations were observed between levels
of TNF-a, IL-1ß and IL-6, between chemokines IP-10 and MIG and between myeloperoxidase, IL-8 and G-CSF. Samples from
women with any STD/colonization had significantly higher levels of IL-8, IL-3, IL-7, IL-1ß, lactoferrin and myeloperoxidase. IL-
1ß and lactoferrin were significantly increased in gonorrhea, Chlamydia, cervicitis, bacterial vaginosis and trichomoniasis.
Conclusions/Significance: These studies show that mucosal fluid in general appears to be an environment that is rich in
immune mediators. Importantly, IL-1ß and lactoferrin are biomarkers for STDs/colonizations providing insights into immune
responses and pathogenesis at this mucosal site.
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Introduction
It is estimated that more than one million new cases of sexually
transmitted diseases (STDs) occur each day worldwide [1]. STDs
in women induce innate and/or adaptive immune responses that
in most cases do not lead to clearance of the microbial infection,
but can cause inflammation and/or influx of immune cells into the
lower genital tract [2]. While not STDs, bacterial vaginosis and
vaginal candidiasis are frequent microbial colonizations encoun-
tered in the setting of the STD clinic that also induce immune
responses in the lower genital tract of women [3,4]. The
combination of the infecting/colonizing microorganisms along
with the induced immune responses and inflammation can have
serious pathologic consequences in women including infertility,
adverse pregnancy outcomes, and increased susceptibility to
infection by other pathogens [1,5].
Identification of the immune mediators that are elicited in the
lower genital tract by STDs and other microbial colonizations can
potentially give important insights into the innate and adaptive
immune pathways that are activated in response to the
microorganisms, how the organisms are able to avoid clearance
by these immune pathways as well as their pathologic mechanism.
For example, some cytokines and chemokines are induced in the
genital tract by STDs and this induction has been associated with
increased susceptibility to infection with HIV suggesting a possible
role for those immune mediators in increasing HIV susceptibility
(Reviewed in [6]). Some genital immune mediators have been
reported to be increased in trichomoniasis, Chlamydia trachomatis
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previous studies of STDs measured limited types of mediators
(e.g. only proinflammatory mediators or chemokines) and the
relationships between mediators and STDs have not been well
defined.
In this study we tested genital mucosal fluid from women
attending an STD clinic for 32 distinct immune mediators. The
mediators measured in this study included pro-inflammatory
cytokines (IL-1ß, TNF-a, IL-6), anti-inflammatory cytokines (IL-4,
IL-10, IL-13), chemokines (MCP-1, RANTES, IL-8, IP-10, MIG,
MIP-1a, MIP-1ß, eotaxin), anti-microbial proteins (ß2defensin,
ß3defensin, lactoferrin), a marker for neutrophils (myeloperoxi-
dase, MPO), interferons (interferon-a and interferon-c), and other
cytokines and growth factors (GM-CSF, G-CSF, IL-3, IL-12, IL-7,
IL-5, vascular endothelial growth factor (VEGF), angiogenin,
fibroblast growth factor (FGF), IL-9 and lymphotoxin-a). The
goals of this study were to determine which of the immune
mediators were detectable at this mucosal site, to determine if
there were any strong associations between the different mediators,
and to investigate the hypothesis that specific types or patterns of
immune mediators would be broadly changed over all STDs or
changed with particular pathogens. Such patterns could provide
biomarkers predictive of pathogenesis and help identify immune
responses important for immune control of pathogens.
Methods
Subjects
All studies were approved by the Institutional review boards of
Rush University Medical Center and Cook County Stroger
Hospital. The study population was recruited at the Ruth M.
Rothstein CORE Center STD Screening Clinic of Cook County
Stroger Hospital. Symptomatic, female patients presenting for an
STD evaluation were approached for study participation and
written informed consent was obtained from all subjects. Standard
of care genital exams were performed and swabs taken for
diagnosis. Cervical-vaginal lavage samples were then obtained by
irrigation of the cervix with 10 mL of non-bacteriostatic sterile
saline, followed by aspiration from the posterior fornix. Urine was
also obtained for a pregnancy test. None of the subjects were
pregnant. The following tests were performed; BD Probetec ET
(Becton Dickinson, Franklin Lakes, NJ) for Chlamydia trachomatis
and Neisseria gonorrhoeae; culture for herpes (serology was not run);
for Syphilis a rapid plasma reagin test (Arlington Scientific, Utah)
was performed and confirmed using passive particle agglutination
(Fujirebio, Malvern, PA); for HIV, an enzyme immunoassay
(Biorad Laboratories, Hercules, CA) was performed and con-
firmed by western blot; for Trichomonas, wet mount examination
and ELISA for the p65 protein (HyTest, Turku, Finland) were
both performed; for bacterial vaginosis, wet mount for clue cells,
vaginal pH, whiff test, and Nugent gram stain were performed; for
Candida a KOH preparation was examined microscopically;
Pelvic Inflammatory Disease and Warts were diagnosed by clinical
exam.
Immunoassays
All immunoassays, except interferon-a, lactoferrin, myeloper-
oxidase (MPO), human ßdefensin2 (HßD2) and human ßdefensin3
(HßD3) utilized Cytometric Bead Arrays (BD Biosciences, San
Jose, CA). The commercial arrays had lower limits of detection of
1–3 pg/ml. Custom cytometric bead arrays were made to detect
interferon-a, lactoferrin and myeloperoxidase by coupling blank
beads (BD CBA Functional Beads) with either rabbit antibody to
interferon-a (US Biological, Swampscott, MA), rabbit antibody to
lactoferrin (Biodesign International, Saco, ME) or rabbit antibody
to myeloperoxidase (ICL Inc., Newberg, OR). Standards for the
custom bead arrays were recombinant human interferon-a2 (Cell
Sciences, Canton, MA), milk lactoferrin (Sigma Chem. Co, St.
Louis, MO) and myeloperoxidase (Calbiochem EMD Chemicals,
Gibbstown, NJ). Sensitivities for the interferon-a , lactoferrin and
myeloperoxidase assays were 15 pg/ml, 30 pg/ml and 30 pg/ml
respectively. All bead arrays were assayed on a FACS Calibur flow
cytometer and levels of cytokines calculated using BD CBA
software. HßD2 and HßD3 were measured by ELISA using
previously described methods [10].
Statistical Analysis
We first performed a summary analysis of the counts of STDs/
conditions and the immune mediators on the 84 subjects.
Correlation coefficients between pairs of the mediators were
computed and the null hypothesis of no linear association was
tested. Univariate logistic regression analyses were performed in
examining the association between having STDs/conditions and
the immune mediators or the clinical factors. Multivariate logistic
regression with stepwise variable selection was then performed on
the significant variables found in the univariate analysis. Subjects
with a particular STD or condition were compared with those
without any STD/condition by logistic regression when the
number of cases was relatively large and by the Fisher exact test
when the number of cases was small. Such analyses were
performed both on subjects having the STD/condition alone
and for all subjects having the STD/condition. No multivariate
analysis was performed for individual STD/condition because of
the sample size limitation.
Results
Subject characteristics
The study population consisted of 84 women, 18 years of age or
older, attending a clinic for STD screening. The largest proportion
of subjects were between 18 and 24 years old (40%), while 33%
were between 25 and 34, 18% were between 35 and 44 and 8%
were between 45 and 54. The subjects were 90% African
American, 7% Latino, and 3% Caucasian.
Of the 84 subjects, 13 had no STD or condition (conditions
included bacterial vaginosis and Candida that are technically not
STDs), 49 subjects had one STD or condition, 20 subjects had 2
STDs or conditions while 3 subjects had 3 STDs or conditions.
The numbers and types of STDs and conditions are shown in
Table 1. The most common diagnosis was bacterial vaginosis
followed by Candida, Chlamydia infection and trichomoniasis.
In the 48 hours prior to cervical-vaginal lavage (CVL) donation,
one woman reported use of a vaginal tampon, five reported
douching, nine reported use of vaginal medications (either
suppositories, creams, jellies, foam, sponge, perfume or lubricant),
23 reported having vaginal sex with a male partner while 2
reported menstrual blood flow (although blood was not evident at
the time of CVL donation). All CVL was tested for semen using
the Abacard test for prostate specific antigen (PSA). Fourteen were
PSA positive, three were PSA +/2 while 67 were PSA negative.
Detection of immune mediators
Table 2 shows the median, mean and range for each of the 32
immune mediators listed from lowest to highest median concen-
tration in CVL samples. Six mediators were detected in all CVL
(IL-1ß, VEGF, angiogenin, IL-8, HßD2 and HßD3) while
interferon-a was the only substance not detected in any of the
CVL samples. Lactoferrin, MPO and GCSF were the three most
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90% and 93% of subjects respectively) while lymphotoxin-a, IL-9
and eotaxin were the three least frequently detected (40% 45%
and 46% respectively). Lymphotoxin-a, IL-13, IL-9, eotaxin,
RANTES, IL-2, IFN-c, IL-5 and MIP-1a were detected too
infrequently to obtain reliable associations with other mediators or
with disease status and therefore were excluded from the further
analysis described below.
Associations between mediators
A number of significant positive associations between the
immune mediators were observed. Associations with Pearson
correlation coefficients .0.7 (strong correlations) are shown in
Table 3. The strongest correlation was between MIG and IP-10,
two IFN-c-induced, CXCR3-binding chemokines that also have
direct anti-bacterial activity [11]. Strong correlations were also
observed between each of the three pro-inflammatory cytokines
TNF-a, IL-1ß and IL-6. MPO, a marker for the presence of
neutrophils, was strongly correlated with IL-8 and G-CSF,
mediators that induce neutrophil migration and support neutro-
phil function, respectively.
No significant strong negative correlations (Pearson correlation
coefficients between 21.0 and 20.7) were observed between any
of the immune mediators possibly reflecting the fact that only a few
of the mediators tested had known activity for down-regulating
immune responses. However, significant (p,0.05), but relatively
weak, negative correlations between HßD2 were observed with IL-
8, IL-1ß, GM-CSF, IP-10, MIG, G-CSF and MPO (Pearson
coefficients ranging from 20.24 to 20.34). Similarly, HßD3 had
negative correlations with TNF-a, IL-4, IL-6, IL-10, IL-1ß, IL-12,
GM-CSF, MCP-1, G-CSF, VEGF and lactoferrin (Pearson
coefficients ranging from 20.24 to 20.42).
Association of mediators with STD/colonization
The subjects that had no STDs or colonization were used as a
control group and compared with all other subjects to determine if
having any STDs/colonization was associated with changes in
levels of immune mediators. When compared to controls, women
with any STD/colonization had significantly higher levels of IL-3,
IL-4, IL-6, IL-8, IL-10, IL-1ß, MIG, G-CSF, VEGF, Angiogenin,
lactoferrin and MPO (Table 4). In a multivariate analysis however,
only MIG and lactoferrin were significantly different between the
two groups (Table 4).
Subjects werefurther sub-categorized as having either no STD or
colonization, only one STD/colonization or several STD/coloni-
zations (Table 5). Compared to the control group, women with only
GC, Chlamydia, cervicitis, bacterial vaginosis or Trichomoniasis
had significantly different levels of 7, 17, 4, 11 and 9 different
immune mediators respectively (Table 5). There were too few
women with HSV, non-specific lesions, warts or PID to obtain
meaningful comparisons with the control group. In general, when
more than one STD/colonization was present (‘‘All’’, Table 5),
more mediators were significantly different than controls (13, 17, 8,
15 and 5 for GC, Chlamydia, cervicitis, bacterial vaginosis (BV) and
trichomoniasis repectively). Most of the significant differences were
increases in mediators when compared to control. However, MIP-
1ß was decreased in trichomoniasis, while HßD2 was decreased in
Chlamydia infection. Strikingly, IL-1ß and lactoferrin were both
significantly increased in all five of the STDs/colonizations. A
varying pattern of significant changes in other mediators was seen.
For example MIP-1a, VEGF and MPO levels were significantly
different than controls in Chlamydia and trichomoniasis but not BV
while in contrast, IL-6, IL-10, GM-CSF, G-CSF, IL-3, IL-7 and IL-
12 were significantly changed in Chlamydia and BV but not
trichomoniasis.
MCP-1, FGF and HßD3 were not significantly changed in any
of the STDs/colonizations, while MIG and IP-10 were not
significantly different in any of the ‘‘only’’ STDs/colonizations.
When viewed in a heat map format, differential patterns of
increases in cytokines in relation to disease were apparent when
comparing levels from subjects with trichomoniasis, bacterial
vaginosis and controls (Fig. 1). Thus, IL-1ß, lactoferrin and IL-8
were increased in both trichomoniasis and BV when compared to
controls. In contrast, IL-12, IL-7, IL-10, IL-3, and IL-4 were
increased in BV when compared to control samples but not in
trichomoniasis.
Interestingly, women with only yeast infection (N=12) did not
have a significant change in any of the immune mediators (not
shown).
Discussion
This study provides several novel observations concerning
immune mediators in genital mucosal fluids of women. First, IL-1ß
and lactoferrin levels were significantly increased when comparing
controls with all infected subjects and when comparing controls
with each of the STDs/colonizations except Candida. Thus,
increased levels of IL-1ß and lactoferrin were the most robust
changes found in this clinic population with IL-1ß levels increased
10-fold and lactoferrin increased 4.5 fold compared to controls.
IL-1ß is a strong inducer of inflammation at mucosal sites and
IL1ß release from cells is mediated by the inflammasome, an
intracellular molecular complex that is the subject of recent intense
interest [12]. The inflammasome is activated not only by microbial
products including peptidoglycans and toxins, but also by host-
derived danger signals such as changes in potassium levels,
extracellular ATP and reactive oxygen species suggesting that
these endogenous and less-specific inducers could be the
commonality that is present in all STDs/colonizations that leads
to IL-1ß production [12]. Lactoferrin is an iron-binding protein
synthesized by neutrophils and epithelial cells and is implicated in
the host defense response against bacterial, fungal and viral
pathogens [13,14,15]. Lactoferrin and IL-1ß are both associated
with increased HIV-1 genital tract shedding in women [16]. Both
lactoferrin and IL-1ß have been reported to be elevated in
Table 1. Frequency of STDs and/or Conditions.
Only All
Bacterial Vaginosis 12 23
Yeast/Candida 12 22
Trichomoniasis 6 12
Chlamydia Trachomatis 5 13
Cervicitis 3 8
Gonorrhea Cervicitis 3 8
Lesions 2 2
Vaginitis 1 2
HSV 0 4
Warts 0 3
PID* 0 2
No Condition 13 13
*Pelvic Inflammatory Disease.
doi:10.1371/journal.pone.0019560.t001
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infection while increased lactoferrin was reported in cervicitis and
trichomoniasis [7,17,18,19,20]. However, elevations of lactoferrin
in Chlamydia infection and Gonorrhea have not been previously
reported and elevated IL-1ß in trichomoniasis, Gonorrhea or
cervicitis have not been previously reported. One study reported
that IL-1ß was not elevated in Trichomonas vaginalis, Chlamydia
trachomatis or Neisseria gonorrhoeae infections [21]. Lactoferrin also is
recognized to be anti-inflammatory and in fact has been shown to
down-regulate IL-1ß-induced inflammation in the skin [22].
Therefore, lactoferrin in the genital tract may counteract the
pro-inflammatory environment induced by IL-1ß and other
cytokines. Lactoferrin was previously found to be associated with
leukocyte levels in CVL samples [23] and in the current study,
lactoferrin was significantly associated with MPO levels
(p,0.0001) although the correlation coefficient of 0.47 did not
achieve the level of the strong correlations shown in Table 3. In
microbicide studies, IL-1ß is considered a marker for inflamma-
tion/damage to the epithelium [24].
Other potentially important findings of this study were that
mucosalfluid in generalappears to be an environment that is rich in
immune mediators, since all of the 32 mediators that were tested,
except one, were detected in at least 40% of the subjects and several
(IL-3, IL-1ß, VEGF, Angiogenin, IL-8, ß-Defensins 2 and 3), were
detected in all of the subjects. To our knowledge, some of the
mediators, including VEGF, angiogenin, FGF, IL-9, IL-7,
lymphotoxin-a and IL-3, had not been previously reported to be
present in female genital secretions. While the role that these
previously-unrecognized mediators play in genital immunity is not
known, several have reported functions that could be important in
immune responses to STDs. For example, angiogenin has anti-
microbial activity against Candida albicans and certain bacteria in
Table 2. Levels of Immune Mediators in CVL.
Mediator* Missing ND Min Median Max Detectable Mean SD
IFN-a 08 4 N D N D N D 0
LT-a 05 1 N D N D 1 4 3 3 3 2
IL-13 0 50 ND ND 50 34 10 8.1
IL-9 0 47 ND ND 74 37 15 12
IFN-c 83 8 N D N D 9 2 3 8 2 5 2 1
Eotaxin 3 46 ND ND 573 35 84 100
IL-4 8 26 ND 1.8 20 50 4 4
IL-10 8 24 ND 2 23 52 5 5
RANTES 5 39 ND 3 178 40 17 30
IL-2 8 24 ND 3 20 52 5 4
TNF-a 82 4 N D 3 1 9 0 5 2 1 3 2 8
MIP-1 a 03 8 N D 3 1 6 2 4 6 1 7 3 2
IL-5 9 2 ND 3 14 73 4 2
IL-3 3 36 ND 3 89 45 10 13
G-CSF 3 6 ND 4 52 75 438 879
GM-CSF 3 17 4 52 64 7 7
IL-6 8 13 ND 5 1736 63 93 312
IL-12 7 8 ND 8 81 69 12 12
MCP-1 5 20 ND 12 2500 59 80 327
MIP-1ß 0 16 ND 21 5714 68 183 729
FGF 0 41 ND 28 86 43 41 12
IL-7 9 18 ND 44 285 57 90 68
IP-10 5 17 ND 54 2500 62 328 590
MIG 5 5 ND 64 2500 74 391 661
IL-1ß 7 0 2.2 184 5082 77 610 1050
VEGF 0 0 33 246 15742 84 627 1813
Angiogenin 0 0 18 459 151800 84 3258 16644
IL-8 7 0 31 3729 5046 77 2909 2085
HBD2 0 0 1.6 7 35 84 9 6
MPO 0 8 ND 369 6400 76 904 1145
HBD3 0 0 1.1 1069 3156 84 1127 839
Lactoferrin 0 10 ND 1741 5198 74 1669 917
Table is arranged from lowest to highest median values. ND: Not Detectable; Mean and SD (Standard Deviation) are computed for the detectable.
The total sample size: N0+N1+N2=84.
*Levels in pg/ml except that HBD2, MPO, HBD3 and Lactoferrin are in ng/ml.
doi:10.1371/journal.pone.0019560.t002
Mucosal Immunity in STDs
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to genital yeast or other infections in women. VEGF has been
postulated to play a role during inflammation and infections by
increasing vascularity and promoting adhesion of leukocytes [26,27].
IL-7 is a crucial survival and expansion factor for T cells [28] and
could therefore play a role in mucosal T cell responses to STDs.
This study also showed strong correlations between several
groups of immune mediators, suggesting possible linkages of
Table 3. Associations Between Mediators with Pearson Correlation Coefficients .0.7.
TNF-a IL-3 IL-6 IL-7 IL-8 IL-10 IL -1b GM-CSF IP-10 MIG G-CSF MPO
TNF-a 1.00 0.70 0.81 0.70
IL-3 1.00 0.81
IL-6 1.00 0.73 0.74 0.83
IL-7 1.00
IL-8 1.00 0.83 0.71 0.84
IL-10 1.00 0.77
IL -1b 1.00 0.77
GM-CSF 1.00
IP-10 1.00
MIG 1.00
G-CSF 1.00
The statistic is the correlation coefficient. Correlation coefficients smaller than 0.7 are suppressed. All displayed correlation coefficients have p-values smaller than 0.0001
in testing the hypothesis of no correlation.
doi:10.1371/journal.pone.0019560.t003
Table 4. Relationships between STDs/Conditions and Immune Mediators.
Mediator* Control (SD) Any STD (SD) Univariate Analysis Multivariate Analysis
OR 95% CI P OR 95% CI P
TNF-a (8) 3 (1) 10 (26)
IL-4 (9) 2 (1) 3 (4) 2.0 1.1, 3.7 0.02
IL-6 (7) 5 (5) 92 (308) 1.9 1.1, 3.3 0.02
IL-10 (9) 2 (2) 4 (5) 2.1 1.1, 4.4 0.03
IP-10 (5) 75 (27) 294 (573)
MCP-1 (5) 24 (5) 67 (305)
MIG (5) 87 (23) 421 (682) 1.5 1.1, 2.1 0.02 1.5 1.0, 2.1 0.04
IL-8 (7) 679 (219) 679 (219) 1.7 1.1, 2.6 0.01
GM-CSF (3) 3 (2) 7 (8)
G-CSF (3) 35 (12) 476 (902) 1.5 1.1, 2.1 0.008
IL-3 (9) 12 (10) 24 (21) 7.4 1.5, 38 0.02
IL-7 (9) 31 (22) 76 (74)
IL-12 (7) 7 (7) 12 (13)
IL-1ß (7) 72 (12) 719 (1103) 1.8 1.2, 2.6 0.003
VEGF (0) 185 (164) 708 (1937) 2.4 1.1, 5.4 0.03
Angiog. (0) 605 (201) 3744 (17829) 1.8 1.1, 3.1 0.03
FGF (0) 27 (35) 20 (22)
MIP-1ß (0) 29 (18) 170 (706)
HBD2 (0) 10 (18) 9 (14)
MPO (0) 217 (92) 928 (1183) 1.3 1.1, 1.7 0.02
Lactof. (0) 370 (176) 1672 (959) 1.4 1.1, 1.7 0.002 1.3 1.1, 1.6 0.008
HBD3 (0) 1446 (1822) 1069 (1585)
Levels in pg/ml except that HBD2, MPO, HBD3 and Lactoferrin are in ng/ml. Any STD includes BV and Candida. Only variables with p-value,0.05 have OR, 95%
confidence interval and p-value shown. The p-values are calculated based on Fisher exact test and the odds ratios are calculated with correction, i.e., by adding 0.5 to
counts if there were zero counts. Only two variables are selected in the final model.
*Number missing in parenthesis.
doi:10.1371/journal.pone.0019560.t004
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MIG had the strongest association and these two chemokines have
many previously described parallels. They are both induced by
interferons, bind to CXCR3, have direct anti-bacterial activity and
are antagonists for CCR3 [11,29]. Strong correlations were also
observed between each of the three pro-inflammatory cytokines
TNF-a, IL-1ß and IL-6 (Table 2). IL-8, which is in some cases
considered a pro-inflammatory mediator, was also strongly
Table 5. P-values in testing association between specific STDs/Conditions and Immune Mediators.
Gonorrhea Chlamydia Cervicitis B. Vaginosis Trichomonas
Only* All* Only All Only All Only All Only All
TNF-a 0.02 0.03 0.008 0.006
IL-4 0.02 0.01 0.02 0.01 0.04
IL-6 0.007 0.004 0.001 0.01 0.03 0.03 0.004
IL-10 0.02 0.01 0.001 0.001 0.01 0.01
IP-10 0.01 0.04 0.03
MIG 0.04 0.003 0.03 0.03 0.01 0.01
IL-8 0.02 0.01 0.001 0.01 0.03 0.002 0.04
GM-CSF 0.02 0.02 0.02 0.007 0.006
G-CSF 0.01 0.001 0.0001 0.0001 0.02 0.009
IL-3 0.05 0.04 0.003 0.004
IL-7 0.01 0.002 0.02 0.006 0.02 0.002
IL-12 0.02 0.02 0.004 0.001 0.0001
IL-1ß 0.007 0.002 0.002 0.0001 0.02 0.005 0.001 0.0001 0.01 0.02
VEGF 0.03 0.02 0.002 0.003 0.004 0.001 0.03
Angiog. 0.03 0.01 0.01 0.004
MIP-1ß 0.02 0.04 0.006 0.05
Lacto. 0.002 0.0003 0.004 0.0001 0.003 0.001 0.001 0.001 0.03
MPO 0.02 0.003 0.002 0.04
HBD2 0.02 0.003 0.002 0.04
Only those p-values,0.05 are shown. Tests are significant after the adjustment of column-wise multiple tests if p-value,0.05/32=0.0016, where 32 is the number of
tests performed, including those mediators tested but not shown.
*Only -subjects that had only one STD/colonization; All –all subjects with that STD/colonization.
doi:10.1371/journal.pone.0019560.t005
Figure 1. Heat map of cytokine levels. The heat map was generated using the web-based program Matrix2png [34] that displays microarray data
visually (http://www.bioinformatics.ubc.ca/matrix2png/). The mean for each row of cytokine values is 0 with red representing values greater than 0,
green lower than 0 and black 0.
doi:10.1371/journal.pone.0019560.g001
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previous studies have noted parallels between several of these
inflammatory mediators in genital fluid from different groups of
women. For example, levels of IL-1ß and IL-6, but not TNF-a,
were significantly elevated in subjects in labor when compared to
those not in labor [30]. In contrast, several studies have shown that
while IL-1ß is increased in bacterial vaginosis, IL-6 and TNF-a are
not [7,31]. In this study, IL-1ß, IL-6 and IL-8 were significantly
increased in bacterial vaginosis while TNF-a was not.
This study had several limitations. Several conditions in the
subjects were not known at the time of sample collection such as
smoking and exact stage of the menstrual cycle which have been
shown to be associated with changes in levels of certain cytokines
[32]. Also, the women used as a control group were those visiting
the STD clinic. Thus it is possible that a group of women with no
risk factors may have had differing levels of immunologic
mediators than the group assessed here. Another limitation of
this study was that samples were collected by cervical vaginal
lavage and therefore the initial concentration of mediators in
undiluted genital fluid is not known. However, collection of
samples by this method would not affect the associations between
mediators that were observed. Further, the numbers of women
infected with herpes are likely to be underestimated in this group
of women since culture was used to determine herpes infection
instead of the more sensitive PCR-based methods [33].
In conclusion this study shows that IL-1ß and lactoferrin are
increased in a broad array of STDs and other genital conditions
potentially providing insights into pathogenesis and immune
responses at this mucosal site. These studies also show that genital
mucosal fluids in women have a wider range of immune mediators
than previously demonstrated.
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